Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark N Wass

Showing results (21-30 of 73) with videos related to

Pageof 8
Sort By:
BMC Genomics|August 17, 2017
Investigating Ebola virus pathogenicity using molecular dynamicsMorena Pappalardo, Francesca Collu, James Macpherson, et al.
Cell Discovery|May 10, 2022
SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatmentDenisa Bojkova, Tamara Rothenburger, Sandra Ciesek, et al.
Cell Research|January 22, 2022
Reduced interferon antagonism but similar drug sensitivity in Omicron variant compared to Delta variant of SARS-CoV-2 isolatesDenisa Bojkova, Marek Widera, Sandra Ciesek, et al.
Journal of Molecular Biology|August 8, 2007
Convergent evolution of enzyme active sites is not a rare phenomenonPier Federico Gherardini, Mark N Wass, Manuela Helmer-Citterich, et al.
Journal of Medical Virology|December 13, 2022
Impact of the COVID-19 pandemic on the circulation of other pathogens in EnglandLauren J Hayes, Hannah Uri, Denisa Bojkova, et al.
Bioinformatics (Oxford, England)|May 17, 2019
Is the Bombali virus pathogenic in humans?Henry J Martell, Stuart G Masterson, Jake E McGreig, et al.
Beilstein Journal of Nanotechnology|November 16, 2019
Incorporation of doxorubicin in different polymer nanoparticles and their anticancer activitySebastian Pieper, Hannah Onafuye, Dennis Mulac, et al.
Beilstein Journal of Nanotechnology|September 11, 2019
Doxorubicin-loaded human serum albumin nanoparticles overcome transporter-mediated drug resistance in drug-adapted cancer cellsHannah Onafuye, Sebastian Pieper, Dennis Mulac, et al.
Nature Protocols|May 8, 2015
The Phyre2 web portal for protein modeling, prediction and analysisLawrence A Kelley, Stefans Mezulis, Christopher M Yates, et al.
Bioinformatics (Oxford, England)|February 16, 2017
Changes associated with Ebola virus adaptation to novel speciesMorena Pappalardo, Ian G Reddin, Diego Cantoni, et al.
Pageof 8

Showing results (21-30 of 73) with videos related to

Sort By:
Pageof 8
BMC Genomics|August 17, 2017
Investigating Ebola virus pathogenicity using molecular dynamicsMorena Pappalardo, Francesca Collu, James Macpherson, et al.
Cell Discovery|May 10, 2022
SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatmentDenisa Bojkova, Tamara Rothenburger, Sandra Ciesek, et al.
Cell Research|January 22, 2022
Reduced interferon antagonism but similar drug sensitivity in Omicron variant compared to Delta variant of SARS-CoV-2 isolatesDenisa Bojkova, Marek Widera, Sandra Ciesek, et al.
Journal of Molecular Biology|August 8, 2007
Convergent evolution of enzyme active sites is not a rare phenomenonPier Federico Gherardini, Mark N Wass, Manuela Helmer-Citterich, et al.
Journal of Medical Virology|December 13, 2022
Impact of the COVID-19 pandemic on the circulation of other pathogens in EnglandLauren J Hayes, Hannah Uri, Denisa Bojkova, et al.
Bioinformatics (Oxford, England)|May 17, 2019
Is the Bombali virus pathogenic in humans?Henry J Martell, Stuart G Masterson, Jake E McGreig, et al.
Beilstein Journal of Nanotechnology|November 16, 2019
Incorporation of doxorubicin in different polymer nanoparticles and their anticancer activitySebastian Pieper, Hannah Onafuye, Dennis Mulac, et al.
Beilstein Journal of Nanotechnology|September 11, 2019
Doxorubicin-loaded human serum albumin nanoparticles overcome transporter-mediated drug resistance in drug-adapted cancer cellsHannah Onafuye, Sebastian Pieper, Dennis Mulac, et al.
Nature Protocols|May 8, 2015
The Phyre2 web portal for protein modeling, prediction and analysisLawrence A Kelley, Stefans Mezulis, Christopher M Yates, et al.
Bioinformatics (Oxford, England)|February 16, 2017
Changes associated with Ebola virus adaptation to novel speciesMorena Pappalardo, Ian G Reddin, Diego Cantoni, et al.
Pageof 8